Improving Survivorship Among Minority Cancer Dyads

Improving Survivorship Outcomes for African American and Latinx Cancer Survivors and Caregiver Dyads Through A Culturally Based Training Program for Underserved Health Professional Students

This proposed intervention centers on improving survivorship outcomes among African American and Latinx cancer survivor and caregiver dyads. As a result, there will be four major outcomes. First, as a result of partnership with minority social institutions (e.g. faith leaders), we will develop an in-depth culturally sensitive curriculum and survivorship care plan for Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs). Second, we will increase knowledge and skills by evaluating a comprehensive cancer survivorship training program designed for underserved health professional students. Third, the implementation of this program will improve survivorship outcomes among African American and Latinx cancer survivors with advanced stage cancer and their caregivers. Lastly, this study will build sustainability for underserved minorities with the training of 30 future healthcare providers as a valuable community resource for improving cancer survivorship outcomes. The long-term outcomes of the CSC LAMPs program will generate workforce capacity and diversity in cancer-based clinical practice, research, and community advocacy for underserved minority cancer survivors and caregivers.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Los Angeles, California, United States, 90059
        • Charles R. Drew University of Medicine & Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Aim 1 Focus Group for Cancer Survivors and Caregivers:

Inclusion Criteria

  • Individuals ages 18 and older
  • identify as African American or Latinx
  • identify as a cancer survivor and/or caregiver
  • speak and/or understand English

Exclusion Criteria

  • individuals ages 17 years or younger
  • does not identify as African American or Latinx
  • unable to speak or understand English
  • does not identify as a cancer survivor or caregiver

Aim 1 Focus Group for Oncology Healthcare Providers:

Inclusion Criteria

  • Individuals ages 18 and older
  • identify as a healthcare provider
  • provide care to cancer patients in current provider role
  • speak and/or understand English

Exclusion Criteria

  • individuals ages 17 years or younger
  • unable to speak or understand English
  • does not provide care to cancer patients
  • does not identify as a healthcare provider

Aim 2:

Inclusion Criteria

  • Individuals ages 18 and older
  • registered as a CDU student
  • speak and/or understand English
  • considered to be underserved, which include a) identifying as an underrepresented minority: Asian, Pacific Islander, African American, Hispanic, and Native American/Alaskan Native and/or b) from a medically underserved population (i.e. faced economic, cultural or linguistic barriers to health care)

Exclusion Criteria

  • individuals ages 17 years or younger
  • not registered as a CDU student
  • unable to speak or understand English
  • not considered to be underserved

For Aim 3:

Inclusion Criteria

  • cancer survivor with a participating caregiver
  • stage III or stage IV cancer diagnosis
  • breast, lung, or colorectal cancer diagnosis
  • identify as African American or Latinx
  • speak and/or understand English

Exclusion Criteria

  • individuals ages 17 years or younger
  • does not identify as African American or Latinx
  • unable to speak or understand English
  • does not identify as a cancer survivor
  • cancer survivor does not identify a caregiver
  • does not have a breast, lung, or colorectal cancer diagnosis
  • not diagnosed with a stage III or stage IV cancer diagnosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Survivorship Management among African American and Latinx Cancer Dyads
This arm will implement a "one group pre-test and posttest" design to improve health outcomes of African American and Latinx cancer survivors and caregivers in collaboration with health professional students trained as Cancer Survivorship and Caregiver Leaders Aimed for Minority Populations (CSC LAMPs).
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to improve survivorship outcomes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Increase in psychosocial well-being using the Quality of Life: Short Form Health Survey and the Center for Epidemiologic Studies Depression Scale
Time Frame: 3 months
By comparison from baseline to post-intervention, there will be a 25% increase in the psychosocial well-being among study participants.
3 months
Reduction of barriers to symptom management Using the Symptom Distress Scale survey
Time Frame: 3 months
By comparison from baseline to post-intervention, there will be a 25% decrease in the barriers to symptom management among study participants.
3 months
3. Decrease in unmet needs Using the Barriers to Follow-Up Care Survey and Cancer Survivors Unmet Needs instrument
Time Frame: 3 months
By comparison from baseline to post-intervention, there will be a 25% decrease in the unmet needs among study participants.
3 months
Reduction in caregiver burden using the Caregiver reaction assessment (CRA) survey
Time Frame: 3 months
By comparison from baseline to post-intervention, there will be a 25% decrease in the caregiver burden among study participants.
3 months
5. Increase knowledge and utilization of supportive services using the Medical Outcomes Study Social Support Survey
Time Frame: 3 months
By comparison from baseline to post-intervention, there will be a 25% increase in the knowledge and utilization of supportive services among study participants.
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sharon Cobb, Charles R. Drew University of Medicine & Science

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 1, 2021

Primary Completion (Anticipated)

June 30, 2024

Study Completion (Anticipated)

December 31, 2024

Study Registration Dates

First Submitted

December 22, 2020

First Submitted That Met QC Criteria

December 22, 2020

First Posted (Actual)

December 28, 2020

Study Record Updates

Last Update Posted (Actual)

July 26, 2022

Last Update Submitted That Met QC Criteria

July 22, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • CancerDyads

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer

Clinical Trials on Change in knowledge, motivation, skills, and resources

3
Subscribe